| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 648.77M | 895.28M | 604.65M | 524.11M |
| Gross Profit | 111.77M | 179.62M | 49.82M | 61.78M |
| EBITDA | -600.13M | -411.22M | -390.08M | -513.78M |
| Net Income | -737.30M | -529.47M | -505.97M | -572.80M |
Balance Sheet | ||||
| Total Assets | 4.69B | 4.04B | 4.14B | 2.49B |
| Cash, Cash Equivalents and Short-Term Investments | 974.39M | 664.51M | 1.47B | 276.22M |
| Total Debt | 1.60B | 1.36B | 1.07B | 1.15B |
| Total Liabilities | 2.75B | 2.29B | 1.90B | 1.96B |
| Stockholders Equity | 2.04B | 2.01B | 2.27B | 566.02M |
Cash Flow | ||||
| Free Cash Flow | -454.90M | -862.46M | -854.56M | -934.79M |
| Operating Cash Flow | -393.22M | -718.40M | -728.06M | -768.21M |
| Investing Cash Flow | -210.03M | 116.80M | -560.34M | -185.47M |
| Financing Cash Flow | 821.62M | 181.41M | 2.09B | 368.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.39B | 4.67 | 15.52% | 4.43% | 6.54% | 3.26% | |
71 Outperform | HK$3.89B | 9.48 | 18.70% | 5.77% | -7.78% | -29.31% | |
71 Outperform | HK$13.65B | 15.46 | 11.18% | 2.78% | -0.95% | 14.89% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | HK$5.26B | 6.75 | 6.10% | 5.22% | 590.98% | 538.64% | |
51 Neutral | HK$12.43B | 11.52 | 74.40% | ― | 4.74% | -21.33% | |
43 Neutral | HK$4.23B | -8.57 | ― | ― | ― | ― |